Ameritas Investment Partners’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$833K Hold
13,268
0.03% 670
2025
Q4
$1.27M Sell
13,268
-238
-2% -$23.3K 0.04% 510
2025
Q3
$1.32M Sell
13,506
-458
-3% -$47.4K 0.04% 497
2025
Q2
$1.5M Sell
13,964
-77
-0.5% -$7.79K 0.05% 449
2025
Q1
$1.42M Sell
14,041
-319
-2% -$32.1K 0.05% 471
2024
Q4
$1.28M Sell
14,360
-556
-4% -$48.9K 0.04% 530
2024
Q3
$1.25M Sell
14,916
-555
-4% -$43.8K 0.04% 548
2024
Q2
$1.19M Sell
15,471
-375
-2% -$27.4K 0.04% 548
2024
Q1
$1.09M Sell
15,846
-425
-3% -$27.3K 0.04% 600
2023
Q4
$941K Sell
16,271
-628
-4% -$33.5K 0.03% 641
2023
Q3
$892K Sell
16,899
-390
-2% -$20.5K 0.04% 611
2023
Q2
$935K Hold
17,289
0.04% 609
2023
Q1
$865K Hold
17,289
0.03% 629
2022
Q4
$793K Sell
17,289
-330
-2% -$14.3K 0.03% 660
2022
Q3
$682K Sell
17,619
-560
-3% -$22.5K 0.03% 653
2022
Q2
$677K Hold
18,179
0.03% 675
2022
Q1
$805K Sell
18,179
-502
-3% -$21.8K 0.03% 684
2021
Q4
$794K Sell
18,681
-521
-3% -$21.9K 0.03% 703
2021
Q3
$833K Sell
19,202
-439
-2% -$19.4K 0.03% 664
2021
Q2
$840K Hold
19,641
0.03% 672
2021
Q1
$759K Sell
19,641
-1,193
-6% -$45.2K 0.03% 684
2020
Q4
$749K Sell
20,834
-1,048
-5% -$37.8K 0.03% 657
2020
Q3
$836K Sell
21,882
-1,125
-5% -$43.4K 0.04% 541
2020
Q2
$808K Buy
23,007
+266
+1% +$9.58K 0.04% 543
2020
Q1
$742K Sell
22,741
-515
-2% -$20.1K 0.04% 480
2019
Q4
$1.05M Sell
23,256
-362
-2% -$15.1K 0.05% 504
2019
Q3
$961K Sell
23,618
-434
-2% -$18.4K 0.04% 517
2019
Q2
$1.03M Sell
24,052
-753
-3% -$29K 0.05% 501
2019
Q1
$952K Buy
24,805
+400
+2% +$15.3K 0.04% 530
2018
Q4
$862K Sell
24,405
-718
-3% -$26K 0.05% 509
2018
Q3
$967K Sell
25,123
-1,049
-4% -$36.6K 0.04% 548
2018
Q2
$856K Sell
26,172
-2,224
-8% -$67.1K 0.04% 587
2018
Q1
$776K Sell
28,396
-1,889
-6% -$51.3K 0.04% 613
2017
Q4
$751K Sell
30,285
-1,080
-3% -$29.8K 0.03% 641
2017
Q3
$864K Hold
31,365
0.04% 577
2017
Q2
$869K Hold
31,365
0.04% 578
2017
Q1
$780K Sell
31,365
-1,167
-4% -$28.4K 0.04% 611
2016
Q4
$704K Hold
32,532
0.04% 656
2016
Q3
$774K Buy
32,532
+5,707
+21% +$136K 0.04% 594
2016
Q2
$627K Buy
26,825
+1,724
+7% +$37.3K 0.04% 495
2016
Q1
$472K Hold
25,101
0.03% 608
2015
Q4
$463K Hold
25,101
0.03% 595
2015
Q3
$412K Hold
25,101
0.03% 633
2015
Q2
$444K Buy
25,101
+701
+3% +$12.5K 0.03% 641
2015
Q1
$433K Hold
24,400
0.03% 666
2014
Q4
$323K Hold
24,400
0.02% 785
2014
Q3
$288K Sell
24,400
-1,455
-6% -$18.3K 0.02% 815
2014
Q2
$330K Sell
25,855
-876
-3% -$11.4K 0.02% 790
2014
Q1
$361K Sell
26,731
-1,297
-5% -$17K 0.03% 709
2013
Q4
$337K Sell
28,028
-661
-2% -$7.81K 0.03% 761
2013
Q3
$337K Buy
+28,689
New +$310K 0.03% 686

Other funds holding BSX

Ameritas Investment Partners's BSX Position: Q1 2026 in Review

Ameritas Investment Partners held its Boston Scientific (BSX) position steady in Q1 2026 at 13,268 shares worth $833K. The position accounts for 0.03% of the portfolio, ranked #670.

Ameritas Investment Partners first reported a position in BSX in Q3 2013 and has held it in 51 quarters since. The position peaked at $1.5M in Q2 2025. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • Ameritas Investment Partners held 13,268 shares of Boston Scientific worth $833K as of Q1 2026.
  • Ameritas Investment Partners left its Boston Scientific share count unchanged in Q1 2026.
  • Boston Scientific made up 0.03% of Ameritas Investment Partners's portfolio in Q1 2026, its #670 holding.
  • Ameritas Investment Partners first reported a position in Boston Scientific in Q3 2013 and has held it in 51 quarters since.
  • Ameritas Investment Partners's Boston Scientific position peaked at $1.5M in Q2 2025.
  • 1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Ameritas Investment Partners's 13F filing for Q1 2026, filed 13 May 2026.